B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?

Primary antiphospholipid syndrome (PAPS) is a systemic autoimmune disease characterized by thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL). Anticoagulants form the mainstay of treatment in PAPS. A growing number of studies suggest a previously underappreciated...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Hoogen, Lucas L., Bisoendial, Radjesh J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821657/
https://www.ncbi.nlm.nih.gov/pubmed/36614819
http://dx.doi.org/10.3390/jcm12010018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821657/
https://www.ncbi.nlm.nih.gov/pubmed/36614819
http://dx.doi.org/10.3390/jcm12010018

Ejemplares similares